Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical’s Annual Report for 2025 highlights its continued efforts in revolutionizing lung imaging technology, particularly through its CT:VQ™ product. The report outlines strategic growth, commercial partnerships, and clinical research initiatives, positioning the company as a leader in the cardiopulmonary imaging sector and indicating a strong outlook for FY26.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical is a global medical technology company focused on transforming patient outcomes for those with lung disease by innovating respiratory imaging through advanced ventilation and perfusion analysis.
Average Trading Volume: 6,156,309
Technical Sentiment Signal: Buy
Current Market Cap: A$767.5M
See more insights into 4DX stock on TipRanks’ Stock Analysis page.